Vilazodone: Clinical Basis for the US Food and Drug Administration’s Approval of a New Antidepressant

Clicks: 130
ID: 112796
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #166 of 273 articles by views in the journal of clinical psychiatry

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 273 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
laughren2011thevilazodone: Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Thomas P. Laughren;Jogarao Gobburu;Robert J. Temple;Ellis F. Unger;Atul Bhattaram;Phillip V. Dinh;Linda Fossom;H. M. James Hung;Violetta Klimek;Jee Eun Lee;
Journal the journal of clinical psychiatry
Year 2011
DOI
DOI not found
URL
https://www.psychiatrist.com/JCP/article/Pages/2011/v72n09/v72n0902.aspx
Keywords
jcp; keywords:depression; keywords:research methods and statistics; j clin psychiatry:jcp categories:depression; j clin psychiatry:jcp categories:research methods and statistics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.